相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparative chemical and biological hydrolytic stability of homologous esters and isosteres
Hygor M. R. de Souza et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)
New developments in tuberculosis diagnosis and treatment
Cara M. Gil et al.
BREATHE (2022)
Activation of benzoate model prodrugs by mycobacteria. Comparison with mammalian plasma and liver hydrolysis
Emilia Valente et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
Newly Developed Prodrugs and Prodrugs in Development; an Insight of the Recent Years
Anas Najjar et al.
MOLECULES (2020)
Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex isolates - the EUCAST broth microdilution reference method for MIC determination
Thomas Schon et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Perspective for Precision Medicine for Tuberculosis
Christoph Lange et al.
FRONTIERS IN IMMUNOLOGY (2020)
Microbial esterases and ester prodrugs: An unlikely marriage for combating antibiotic resistance
Erik M. Larsen et al.
DRUG DEVELOPMENT RESEARCH (2019)
The prodrug approach in the era of drug design
Anas Najjar et al.
EXPERT OPINION ON DRUG DELIVERY (2019)
The expanding role of prodrugs in contemporary drug design and development
Jarkko Rautio et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Reversion of antibiotic resistance in Mycobacterium tuberculosis by spiroisoxazoline SMARt-420
Nicolas Blondiaux et al.
SCIENCE (2017)
Esterase mutation is a mechanism of resistance to antimalarial compounds
Eva S. Istvan et al.
NATURE COMMUNICATIONS (2017)
Profiling Esterases in Mycobacterium tuberculosis Using Far-Red Fluorogenic Substrates
Katie R. Tallman et al.
ACS CHEMICAL BIOLOGY (2016)
Small-Molecule Probes Reveal Esterases with Persistent Activity in Dormant and Reactivating Mycobacterium tuberculosis
Katie R. Tallman et al.
ACS INFECTIOUS DISEASES (2016)
Esters of Pyrazinoic Acid Are Active against Pyrazinamide-Resistant Strains of Mycobacterium tuberculosis and Other Naturally Resistant Mycobacteria In Vitro and Ex Vivo within Macrophages
David Pires et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Antimycobacterial Assessment of Salicylanilide Benzoates including Multidrug-Resistant Tuberculosis Strains
Martin Kratky et al.
MOLECULES (2012)
Lipophilic pyrazinoic acid amide and ester prodrugs Stability, activation and activity against M. tuberculosis
Marta Filipa Simoes et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Enhancement of the antituberculosis activity of weak acids by inhibitors of energy metabolism but not by anaerobiosis suggests that weak acids act differently from the front-line tuberculosis drug pyrazinamide
Peihua Gu et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2008)
Effects of weak acids, UV and proton motive force inhibitors on pyrazinamide activity against Mycobacterium tuberculosis in vitro
Mary Margaret Wade et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: Challenges to the discovery scientist
K Beaumont et al.
CURRENT DRUG METABOLISM (2003)
Susceptibility of Mycobacterium tuberculosis to weak acids
Y Zhang et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv
JC Camus et al.
MICROBIOLOGY-SGM (2002)
分享论文
